The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines
Abstract
Oxidative stress and mitochondrial oxidative damage have been implicated in aging and many common diseases. Mitochondria are a primary source of reactive oxygen species (ROS) in the cell, and are particularly susceptible to oxidative damage. Oxidative damage to mitochondria results in mitochondrial permeability transition (MPT), mitochondrial depolarization, further ROS production, swelling, and release of cytochrome c (cyt c). Cytosolic cyt c triggers apoptosis by activating the caspase cascade. In the present work, we examined the ability of a novel cell-penetrating, mitochondria-targeted peptide antioxidant in protecting against oxidant-induced mitochondrial dysfunction and apoptosis in two neuronal cell lines. Treatment with tert-butyl hydroperoxide (tBHP) for 24 h resulted in lipid peroxidation and significant cell death via apoptosis in both N2A and SH-SY5Y cells, with phosphatidylserine translocation, nuclear condensation and increased caspase activity. Cells treated with tBHP showed significant increase in intracellular ROS, mitochondrial depolarization and reduced mitochondrial viability. Concurrent treatment with <1 nM SS-31 (D-Arg-Dmt-Lys-Phe-NH2; Dmt = 2',6'-dimethyltyrosine) significantly decreased intracellular ROS, increased mitochondrial potential, and prevented tBHP-induced apoptosis. The remarkable potency of SS-31 can be explained by its extensive cellular uptake and selective partitioning into mitochondria. Intracellular concentrations of [3H]SS-31 were 6-fold higher than extracellular concentrations. Studies using isolated mitochondria revealed that [3H]SS-31 was concentrated approximately 5000-fold in the mitochondrial pellet. By concentrating in the inner mitochondrial membrane, SS-31 is localized to the site of ROS production, and can therefore protect against mitochondrial oxidative damage and further ROS production. SS-31 represents a novel platform of mitochondria-targeted antioxidants with broad therapeutic potential.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SS-31 protects neuronal cells against tert-butyl-hydroperoxide (tBHP) induced mitochondrial depolarization and apoptotic cell death by reducing intracellular ROS, decreasing markers of apoptotic cell death and caspase activity177.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [177]
Citations
Cites
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
Liu, X., Kim, C. N., Yang, J., Jemmerson, R., & Wang, X. (1996) · Cell · doi:10.1016/s0092-8674(00)80085-9 · Cited by 5,167
Selective Targeting of a Redox-active Ubiquinone to Mitochondria within Cells
Kelso, G. F., Porteous, C. M., Coulter, C. V., Hughes, G., Porteous, W. K., Ledgerwood, E. C., Smith, R. A. J., & Murphy, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009093200 · Cited by 1,091
Mitochondrial permeability transition and oxidative stress
Kowaltowski, A. J., Castilho, R. F., & Vercesi, A. E. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02316-x · Cited by 832
Zhao, K., Zhao, G.-M., Wu, D., Soong, Y., Birk, A. V., Schiller, P. W., & Szeto, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402999200 · Cited by 782
Self-citationMark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010255.x · Cited by 781
Mitochondrial Generation of Reactive Oxygen Species and its Role in Aerobic Life
Inoue, M., Sato, E. F., Nishikawa, M., Park, A.-M., Kira, Y., Imada, I., & Utsumi, K. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033456477 · Cited by 459
Drug delivery to mitochondria: the key to mitochondrial medicine
Murphy, M. P., & Smith, R. A. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00069-1 · Cited by 429
Mitochondrial permeability transition in CNS trauma: Cause or effect of neuronal cell death?
Sullivan, P. G., Rabchevsky, A. G., Waldmeier, P. C., & Springer, J. E. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20292 · Cited by 387
Nieminen, A. L., Saylor, A. K., Tesfai, S. A., Herman, B. A., & Lemasters, J. J. (1995) · Biochemical Journal · doi:10.1042/bj3070099 · Cited by 381
Flagged first, then by citations
Research works printed but not linked: 1
- Martin, 2001, tert-Butyl hydroperoxide-induced lipid signaling in hepatocytes: involvement of glutathione and free radicals, Biochem Pharmacol, 62, 705
Cited by
Sorted by citations
Mitochondrial dysfunction and oxidative stress in heart disease
Peoples, J. N., Saraf, A., Ghazal, N., Pham, T. T., & Kwong, J. Q. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0355-7 · Cited by 950
Oxidative Stress and Neurotoxicity
Sayre, L. M., Perry, G. L., & Smith, M. A. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700210j · Cited by 884
Samaranayaka, A., & Li‐Chan, E. C. Y. (2011) · Journal of Functional Foods · doi:10.1016/j.jff.2011.05.006 · Cited by 797
Hoye, A. T., Davoren, J. E., Wipf, P., Fink, M. P., & Kagan, V. E. (2008) · Accounts of Chemical Research · doi:10.1021/ar700135m · Cited by 643
Szeto, H. H. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12461 · Cited by 561
Self-citationSources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
Birk, A. V., Liu, S., Soong, Y., Mills, W., Singh, P., Warren, J. D., Seshan, S. V., Pardee, J. D., & Szeto, H. H. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012121216 · Cited by 479
Self-citationMitochondrial Diseases of the Brain
Chaturvedi, R. K., & Beal, M. F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.018 · Cited by 426
Neuroprotective strategies involving ROS in Alzheimer disease
Dumont, M., & Beal, M. F. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.026 · Cited by 402
Mitochondrial Targeted Antioxidant Peptide Ameliorates Hypertensive Cardiomyopathy
Dai, D., Chen, T., Szeto, H. H., Nieves‐Cintrón, M., Kutyavin, V. I., Santana, L. F., & Rabinovitch, P. S. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.12.044 · Cited by 367
Self-citationJin, H., Kanthasamy, A., Ghosh, A., Anantharam, V., Kalyanaraman, B., & Kanthasamy, A. G. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.007 · Cited by 373
Daiber, A. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.01.032 · Cited by 347
Cardiac Aging: From Molecular Mechanisms to Significance in Human Health and Disease
Dai, D.-F., Chen, T., Johnson, S. C., Szeto, H., & Rabinovitch, P. S. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4179 · Cited by 334
Self-citationMitochondria-targeted peptide antioxidants: Novel neuroprotective agents
Szeto, H. H. (2006) · The AAPS Journal · doi:10.1208/aapsj080362 · Cited by 332
Self-citationTargeting Mitochondria with Organelle‐Specific Compounds: Strategies and Applications
Yousif, L. F., Stewart, K. M., & Kelley, S. O. (2009) · ChemBioChem · doi:10.1002/cbic.200900185 · Cited by 337
Birk, A., Chao, W. M., Bracken, C., Warren, J. D., & Szeto, H. H. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12468 · Cited by 309
Self-citationMitochondrial Approaches for Neuroprotection
Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294
Mitochondria: A therapeutic target in neurodegeneration
Moreira, P. I., Zhu, X., Wang, X., Lee, H., Nunomura, A., Petersen, R. B., Perry, G. L., & Smith, M. A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.007 · Cited by 292
Reactive Oxygen Species: Stuck in the Middle of Neurodegeneration
Patten, D. A., Germain, M., Kelly, M., & Slack, R. S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100498 · Cited by 286
Mitochondria-Targeted Cytoprotective Peptides for Ischemia–Reperfusion Injury
Szeto, H. H. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1892 · Cited by 274
Self-citationPowers, S. K., Hudson, M. B., Nelson, W. B., Talbert, E. E., Min, K., Szeto, H. H., Kavazis, A. N., & Smuder, A. J. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182190b62 · Cited by 255
Oxidative stress disrupts oligodendrocyte maturation
French, H. M., Reid, M., Mamontov, P., Simmons, R. A., & Grinspan, J. B. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22139 · Cited by 246
Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer’s Disease
Sharma, C., Kim, S., Nam, Y., Jung, U. J., & Kim, S. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094850 · Cited by 253
Saâdi, S., Saari, N., Anwar, F., Hamid, A. A., & Ghazali, H. M. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.12.003 · Cited by 223
Cunha‐Oliveira, T., Montezinho, L., Mendes, C., Firuzi, O., Saso, L., Oliveira, P. J., & Silva, F. S. G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5021694 · Cited by 220
Zhao, W., Xu, Z., Cao, J., Fu, Q., Wu, Y., Zhang, X., Yue, L., Zhang, X., Yang, Y., Li, Y., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1627-9 · Cited by 211
Enzymatic Cleavage of Branched Peptides for Targeting Mitochondria
He, H., Wang, J., Wang, H., Zhou, N., Yang, D., Green, D. R., & Xu, B. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b11582 · Cited by 195
Induction of ferroptosis and mitochondrial dysfunction by oxidative stress in PC12 cells
Wu, C., Zhao, W., Yu, J. Z., Li, S., Lin, L., & Chen, X. (2018) · Scientific Reports · doi:10.1038/s41598-017-18935-1 · Cited by 195
Macrophage Delivery of Therapeutic Nanozymes in A Murine Model of Parkinson‘S Disease
Brynskikh, A. M., Zhao, Y., Mosley, R. L., Li, S., Boska, M. D., Klyachko, N. L., Kabanov, A. V., Gendelman, H. E., & Batrakova, E. V. (2010) · Nanomedicine · doi:10.2217/nnm.10.7 · Cited by 190
Schroeder, E. K., Kelsey, N. A., Doyle, J., Breed, E. R., Bouchard, R. J., Loucks, F. A., Harbison, R. A., & Linseman, D. A. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2215 · Cited by 178
Mitochondria as a target in treatment
Frantz, M., & Wipf, P. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20554 · Cited by 183
Cho, S., Szeto, H. H., Kim, E., Kim, H., Tolhurst, A. T., & Pinto, J. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609388200 · Cited by 170
Self-citationNovel Therapies Targeting Inner Mitochondrial Membrane—From Discovery to Clinical Development
Szeto, H. H., & Schiller, P. W. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0476-8 · Cited by 175
Self-citationYang, L., Zhao, K., Calingasan, N. Y., Luo, G., Szeto, H. H., & Beal, M. F. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2445 · Cited by 168
Self-citationPetri, S., Kiaei, M., Damiano, M., Hiller, A., Wille, E., Manfredi, G., Calingasan, N. Y., Szeto, H. H., & Beal, M. F. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04018.x · Cited by 166
Self-citationBrain mitochondrial dysfunction in aging, neurodegeneration and Parkinson's disease
Navarro, A. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00034 · Cited by 162
Reddy, P. H. (2006) · BioMed Research International · doi:10.1155/jbb/2006/31372 · Cited by 154
Kloner, R. A., Hale, S. L., Dai, W., Gorman, R. C., Shuto, T., Koomalsingh, K. J., Gorman, J. H., Sloan, R. C., Frasier, C. R., Watson, C. A., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.001644 · Cited by 155
Potent mitochondria-targeted peptides reduce myocardial infarction in rats
Cho, J., Won, K., Wu, D., Soong, Y., Liu, S., Szeto, H. H., & Hong, M. K. (2007) · Coronary Artery Disease · doi:10.1097/01.mca.0000236285.71683.b6 · Cited by 144
Self-citationHaney, M. J., Zhao, Y., Harrison, E. B., Mahajan, V., Ahmed, S., He, Z., Suresh, P., Hingtgen, S., Klyachko, N. L., Mosley, R. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061852 · Cited by 144
RetractedMitochondrial dysfunction and mitochondrial therapies in heart failure
Wu, C., Zhang, Z., Zhang, W., & Liu, X. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106038 · Cited by 148
Gruber, J., Fong, S., Chen, C.-B., Yoong, S. L., Pastorin, G., Schaffer, S., Cheah, I. K.-M., & Halliwell, B. B. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.09.005 · Cited by 143
Cell-penetrating peptides in protein mimicry and cancer therapeutics
Zorko, M., Jones, S., & Langel, Ü. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114044 · Cited by 136
Gpx4 protects mitochondrial ATP generation against oxidative damage
Liang, H., Remmen, H. V., Frohlich, V. C., Lechleiter, J. D., Richardson, A., & Ran, Q. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.045 · Cited by 128
Mitochondrial dynamics, a key executioner in neurodegenerative diseases
Panchal, K., & Tiwari, A. K. (2018) · Mitochondrion · doi:10.1016/j.mito.2018.11.002 · Cited by 128
Mitchell, W., Ng, E. A., Tamucci, J. D., Boyd, K. J., Sathappa, M., Coscia, A., Pan, M., Han, X., Eddy, N. A., May, E. R., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012094 · Cited by 133
Self-citationMitochondrial dysfunction and skeletal muscle atrophy: Causes, mechanisms, and treatment strategies
Kubat, G. B., Bouhamida, E., Ülger, Ö., Türkel, İ., Pedriali, G., Ramaccini, D., Ekinci, Ö., Özerkliğ, B., Atalay, Ö., Patergnani, S., et al. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.07.003 · Cited by 134
Brand, M. D. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1828258 · Cited by 123
Mitochondria: a new therapeutic target in chronic kidney disease
Granata, S., Gassa, A. D., Tomei, P., Lupo, A., & Zaza, G. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0044-z · Cited by 122
Hou, Y., Li, S., Wu, M. T., Wei, J., Ren, Y., Du, C., Wu, H., Han, C., Duan, H., & Shi, Y. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00574.2014 · Cited by 124
Mitochondrial protection restores renal function in swine atherosclerotic renovascular disease
Eirin, A., Ebrahimi, B., Zhang, X., Zhu, X.-Y., Woollard, J. R., He, Q., Textor, S. C., Lerman, A., & Lerman, L. O. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu157 · Cited by 110
Wang, S., Sun‐Waterhouse, D., Waterhouse, G. I. N., Zheng, L. P., Su, G., & Zhao, M. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.04.056 · Cited by 113
Hemigramicidin–TEMPO conjugates: Novel mitochondria-targeted anti-oxidants
Fink, M. P., Macias, C. A., Xiao, J., Tyurina, Y. Y., Jiang, J., Belikova, N. A., Delude, R. L., Greenberger, J. S., Kagan, V. E., & Wipf, P. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.05.019 · Cited by 107
The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson's Disease
Camilleri, A., & Vassallo, N. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12264 · Cited by 106
Can Antioxidants Protect Against Disuse Muscle Atrophy?
Powers, S. K. (2014) · Sports Medicine · doi:10.1007/s40279-014-0255-x · Cited by 103
Development of Mitochondria‐targeted Aromatic‐cationic Peptides for Neurodegenerative Diseases
Szeto, H. H. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.013 · Cited by 100
Self-citationHuang, M., Myers, C. R., Wang, Y., & You, M. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0425 · Cited by 99
Cell-penetrating peptides with intracellular organelle targeting
Cerrato, C. P., Künnapuu, K., & Langel, Ü. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1213237 · Cited by 94
Anti-Cancer Peptides: Status and Future Prospects
Ghaly, G., Tallima, H., Dabbish, E., ElDin, N. B., El‐Rahman, M. K. A., Ibrahim, M. A. A., & Shoeib, T. (2023) · Molecules · doi:10.3390/molecules28031148 · Cited by 92
Szeto, H. H., & Liu, S. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.10.013 · Cited by 89
Self-citationNavarro, A., & Boveris, A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.05.002 · Cited by 88
Thomas, D. A., Stauffer, C., Zhao, K., Yang, H., Sharma, V. K., Szeto, H. H., & Suthanthiran, M. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080825 · Cited by 84
Self-citationBarhe, T. A., & Tchouya, G. R. F. (2014) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2014.11.048 · Cited by 83
Martínez-Pastor, F., Aisen, E., Fernández-Santos, M., Esteso, M., Maroto-Morales, A., García-Álvarez, O., & Garde, J. (2009) · Reproduction · doi:10.1530/rep-08-0357 · Cited by 87
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy
Karaa, A., Bertini, E., Carelli, V., Cohen, B. H., Enns, G. M., Falk, M. J., Goldstein, A., Gorman, G. S., Haas, R., Hirano, M., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207402 · Cited by 82
Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
Mounsey, R. B., & Teismann, P. (2010) · Parkinson s Disease · doi:10.4061/2011/617472 · Cited by 86
Antioxidant and anti-aging activities of the polysaccharide TLH-3 from Tricholoma lobayense
Ding, Q., Yang, D., Zhang, W., Lu, Y., Zhang, M., Wang, L., Li, X., Zhou, L., Wu, Q.-X., Pan, W., et al. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.12.058 · Cited by 82
Chakrabarti, A. K., Kostka, K., Abueg, C., Brown, D. A., Czyz, E., Tendera, M., Jánosi, A., Giugliano, R. P., Kloner, R. A., Weaver, W. D., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2012.12.008 · Cited by 81
Hemigramicidin-TEMPO conjugates: Novel mitochondria-targeted antioxidants
Fink, M. P., Macias, C. A., Xiao, J., Tyurina, Y. Y., Delude, R. L., Greenberger, J. S., Kagan, V. E., & Wipf, P. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000279192.96303.e7 · Cited by 79
Parodi‐Rullán, R. M., Javadov, S. A., & Fossati, S. (2021) · Cells · doi:10.3390/cells10112903 · Cited by 75
Mitochondria and reactive oxygen species in renal cancer
Hervouet, É., Simonnet, H., & Godinot, C. (2007) · Biochimie · doi:10.1016/j.biochi.2007.03.010 · Cited by 74
Oxidative stress by antimicrobial peptide pleurocidin triggers apoptosis in Candida albicans
Cho, J., & Lee, D. G. (2011) · Biochimie · doi:10.1016/j.biochi.2011.07.011 · Cited by 74
Mizuguchi, Y., Chen, J., Seshan, S. V., Poppas, D. P., Szeto, H. H., & Felsen, D. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00395.2007 · Cited by 72
Self-citationKasote, D. M., Hegde, M. V., & Katyare, S. S. (2013) · BioFactors · doi:10.1002/biof.1093 · Cited by 73
Li, J., Chen, X., Xiao, W., Ma, W., Li, T., Huang, J., Liu, X., Liang, X., Tang, S., & Luo, Y. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.122 · Cited by 71
Koju, N., Taleb, A., Zhou, J., Ge, L., Yang, J., Cao, X., Lei, H., & Ding, Q. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.128 · Cited by 72
A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy
Karaa, A., Haas, R., Goldstein, A. C., Vockley, J. E., & Cohen, B. H. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12559 · Cited by 68
Kim, Y.-S., Hwang, J.-W., Sung, S.-H., Jeon, Y., Jeong, J.-H., Jeon, B.-T., Moon, S.-H., & Park, P. (2014) · Food Chemistry · doi:10.1016/j.foodchem.2014.07.106 · Cited by 67
Eirin, A., Ebrahimi, B., Kwon, S. H., Fiala, J. A., WILLIAMS, B. J., Woollard, J. R., He, Q., Gupta, R. C., Sabbah, H. N., Prakash, Y. S., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003118 · Cited by 67
Mitochondrial-targeted penetrating peptide delivery for cancer therapy
Wu, J., Li, J., Wang, H., & Liu, C.-B. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1517750 · Cited by 67
Wang, S., Mf, H., Yh, C., My, W., Xm, Y., Bai, J., Hy, Z., Wang, Y.-Y., Zhao, H., Mei, Q., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.352 · Cited by 66
Wang, X., Liu, X., Shi, N., Zhang, Z., Chen, Y., Yan, M., & Li, Y. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.134966 · Cited by 63
Mitochondria-Targeted Drug Delivery in Cardiovascular Disease: A Long Road to Nano-Cardio Medicine
Forini, F., Canale, P., Nicolini, G., & Iervasi, G. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111122 · Cited by 63
Xia, Y., Zhang, Y., Du, Y., Wang, Z., Cheng, L., & Du, Z. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02503-7 · Cited by 63
Mitochondrial therapies for Parkinson's disease
Thomas, B., & Beal, M. F. (2010) · Movement Disorders · doi:10.1002/mds.22781 · Cited by 62
Dramatic increase in readthrough acetylcholinesterase in a cellular model of oxidative stress
Härtl, R., Gleinich, A. S., & Zimmermann, M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07164.x · Cited by 61
Moreira, E. L. G., Rial, D., Aguiar, A. S., Figueiredo, C. P., Siqueira, J. M., DalBó, S., Horst, H., de Oliveira, J., Mancini, G., dos Santos, T. S., et al. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0464-x · Cited by 61
Mitochondria‐Targeted Antioxidant SkQ1 Prevents Anesthesia‐Induced Dry Eye Syndrome
Zernii, E. Y., Gancharova, O. S., Baksheeva, V. E., Golovastova, M. O., Kabanova, E. I., Savchenko, M. S., Tiulina, V. V., Sotnikova, L. F., Zamyatnin, A. A., Philippov, P. P., et al. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9281519 · Cited by 59
Sodhi, K., Puri, N., Inoue, K., Falck, J. R., Schwartzman, M. L., & Abraham, N. G. (2011) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2011.12.004 · Cited by 57
Toyama, S., Shimoyama, N., Ishida, Y., Koyasu, T., Szeto, H. H., & Shimoyama, M. (2013) · Anesthesiology · doi:10.1097/01.anes.0000435634.34709.65 · Cited by 59
Self-citationKim, E., Tolhurst, A. T., Szeto, H. H., & Cho, S. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12326 · Cited by 57
Self-citationA mitochondrial therapeutic reverses diabetic visual decline
Alam, N. M., Mills, W., Wong, A. A., Douglas, R. M., Szeto, H. H., & Prusky, G. T. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.020248 · Cited by 54
Self-citationCationic amphiphilic polyproline helix P11LRR targets intracellular mitochondria
Li, L., Geisler, I. M., Chmielewski, J. A., & Cheng, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.012 · Cited by 55
Mitochondrial oxidative stress and mammalian healthspan
Wanagat, J., Dai, D., & Rabinovitch, P. S. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.06.002 · Cited by 52
Friedemann, T., Otto, B., Klätschke, K., Schumacher, U., Yi, T., Leung, A. K., Efferth, T., & Schröder, S. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.06.004 · Cited by 51
trans-Resveratrol as A Neuroprotectant
Robb, E. L., & Stuart, J. A. (2010) · Molecules · doi:10.3390/molecules15031196 · Cited by 52
Edens, B. M., Miller, N., & Ma, Y. C. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00044 · Cited by 52
Epoxyeicosatrienoic Acid as Therapy for Diabetic and Ischemic Cardiomyopathy
Romashko, M. D., Schragenheim, J., Abraham, N. G., & McClung, J. A. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.08.001 · Cited by 50
Neuroprotective Activity of Coptisine fromCoptis chinensis(Franch)
Friedemann, T., Schumacher, U., Yi, T., Leung, A. K., & Schröder, S. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/827308 · Cited by 48
Szeto, H. H., Liu, S., Soong, Y., & Birk, A. V. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00366.2014 · Cited by 49
Self-citation
Metadata
- Authors
- Zhao, K., Luo, G., Giannelli, S., & Szeto, H. H.
- Affiliations
- Cornell University (US)
- Corresponding author
- Szeto, Hazel H.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 70
- Issue
- 12
- Pages
- 1796-1806
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2032478715
- Cited by
- 251
- References
- 49
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 16 · 2023: 19 · 2022: 13 · 2021: 15 · 2020: 9 · 2019: 13 · 2018: 11 · 2017: 9 · 2016: 12 · 2015: 14 · 2014: 16 · 2013: 19 · 2012: 7
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA08924, P01DA008924)
- National Institute of Neurological Disorders and Stroke (R21NS048295, NS-48295)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- mitochondria-targeted peptide, SS-31, tert-butyl hydroperoxide, oxidative stress, mitochondrial depolarization, apoptosis, reactive oxygen species, mitochondrial permeability transition, cytochrome c release, lipid peroxidation, neuronal cell lines, N2a cells, SH-SY5Y cells, caspase activation, mitochondrial membrane potential
- MeSH terms
- Mitochondrial Permeability Transition Pore, Antioxidants, Cell Line, Humans, Ion Channels, Mitochondria, Neurons, Oligopeptides, Lipid Peroxidation, Apoptosis, Reactive Oxygen Species, tert-Butylhydroperoxide, Caspases, Mitochondrial Membrane Transport Proteins, Caspase 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review